Among the various public portfolio startups of the fund, we may underline Genetron Health Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Medical Device.
The top activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Shenshang Xingye Fund, startups are often financed by Zhongyuan Union Cell & Gene Eng, Share Capital, New Horizon Capital. The meaningful sponsors for the fund in investment in the same round are Zhongjin Kangrui Medical Industrial Fund, V Star Capital. In the next rounds fund is usually obtained by Vivo Capital, Highlight Capital, Alexandria Venture Investments.
| Fund Name | Location |
| American RENOLIT Corporation | New Jersey, Swedesboro, United States |
| Archimedes Labs | California, Palo Alto, United States |
| Beijing Yanhuang | Beijing, China, Fangshan |
| Cboe FX Markets | New York, New York, United States |
| Crabtree & Evelyn | Connecticut, United States, Woodstock |
| Derbi Foundation | Bangalore, India, Karnataka |
| Granite Hacarmel | HaMerkaz, Israel, Netanya |
| Gray Ventures | Atlanta, Georgia, United States |
| Hongshan Fund | China, Ürümqi, Xinjiang |
| Industrial Bank | China, Foochow, Fujian |
| John Lewis & Partners | England, London, United Kingdom |
| LeadinWay | Hsinchu, Taiwan, Taiwan Province |
| Martlet Venture Management | Canada, Montréal, Quebec |
| Momo | Beijing, Beijing, China |
| PBJ Capital | Lincoln, Massachusetts, United States |
| Pentech Ventures | City of Edinburgh, Scotland, United Kingdom |
| Qianhai Zhongwei Capital | China, Guangdong, Shenzhen |
| US Angel Investors | California, Palo Alto, United States |
| Wei Fund | Canada, Ontario, Toronto |
| WS Ventures Management | Dallas, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Genetron Health | $61M | 04 Jan 2018 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Genetron Health | $61M | 04 Jan 2018 | Dongcheng District, Beijing, China |
